首页 | 本学科首页   官方微博 | 高级检索  
检索        

99mTc-转铁蛋白-DTPA-Gd核素/磁性双模态分子影像探针基于转铁蛋白受体表达水平的肿瘤成像
引用本文:顾丙新,孙玉云,杨忠毅,罗建民,张建平,章英剑.99mTc-转铁蛋白-DTPA-Gd核素/磁性双模态分子影像探针基于转铁蛋白受体表达水平的肿瘤成像[J].中国癌症杂志,2019,29(2):119-124.
作者姓名:顾丙新  孙玉云  杨忠毅  罗建民  张建平  章英剑
作者单位:1. 复旦大学附属肿瘤医院核医学科,复旦大学上海医学院肿瘤学系,上海 200032 ; 2. 复旦大学生物医学影像研究中心,上海 200032 ; 3. 上海分子影像探针工程技术研究中心,上海 200032
基金项目:上海分子影像探针工程技术研究中心项目(14DZ2251400)。
摘    要:背景与目的:转铁蛋白(Holo-Transferrin,Tf)受体(transferrin receptor,TfR)广泛存在于恶性肿瘤细胞膜表面,并被认为是抗肿瘤治疗的靶点。本研究旨在探讨99mTc-Tf-DTPA-Gd在体、无创性检测多种人源性肿瘤TfR表达情况的可行性。方法:制作10种人肿瘤细胞的BALB/c裸小鼠移植瘤模型;经荷瘤鼠尾静脉注射99mTc-Tf-DTPA-Gd或Tf-DTPA-Gd 4 h后行单光子发射计算机断层摄影术(single-photon emission computed tomography,SPECT)/计算机断层摄影术(computed tomography,CT)或磁共振成像(magnetic resonance imaging,MRI)检查,勾画感兴趣区(region of interest,ROI),计算靶本比值即靶区/肌肉组织(target-to-muscle ratios,T/M)或相对信号增强值(relative signal enhancement,rSE);显像结束后取肿瘤组织行H-E染色及免疫组织化学染色,采用H-score法评估10种肿瘤表达TfR水平。选用两样本t检验及Spearman分析数据。结果:10种移植瘤模型均可用于成像。注射双模态探针4 h后,有9种肿瘤摄取99mTc-Tf-DTPA-Gd,其中胶质瘤细胞U87的T/M值最高,乳腺癌细胞MDA-MB-468也有较高的T/M值;而前列腺癌细胞PC-3肿瘤几乎不摄取,T/M值接近1,与MDA-MB-468 T/M值相比差异有统计学意义(t=6.919,P=0.002)。MRI显示,MDA-MB-468肿瘤强化明显,rSE达(154.88±8.71)%,而PC-3肿瘤为(111.31±3.46)%,差异有统计学意义(t=8.441,P=0.001)。PC-3肿瘤几乎不表达TfR,其余9种肿瘤均不同程度地表达TfR。TfR免疫组织化学检测结果与探针的T/M值呈明显的正相关(相关系数为r=0.915,P<0.001)。结论:99mTc-Tf-DTPA-Gd可在体、无创性反映肿瘤表达TfR受体情况。

关 键 词:转铁蛋白受体  分子影像  双模态  磁共振成像  免疫组织化学  

A dual-modality SPECT/MR probe of 99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expression in vivo
GU Bingxin,SUN Yuyun,YANG Zhongyi,LUO Jianmin,ZHANG Jianping,ZHANG Yingjian.A dual-modality SPECT/MR probe of 99mTc-Transferrin-DTPA-Gd for the detection of tumor transferrin receptor expression in vivo[J].China Oncology,2019,29(2):119-124.
Authors:GU Bingxin  SUN Yuyun  YANG Zhongyi  LUO Jianmin  ZHANG Jianping  ZHANG Yingjian
Institution:1. Department of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 2. Center for Biomedical Imaging, Fudan University, Shanghai 200032, China; 3. Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai 200032, China
Abstract:Background and purpose: Transferrin (Tf) receptor (TfR) is expressed broadly in malignant cells, and has been developed as a target for anti-tumor therapy. This study aimed to investigate the feasibility of 99mTc-Tf-DTPA-Gd noninvasively detecting tumor TfR expression in vivo. Methods: We established 10 xenograft tumor models with mice. 99mTc-Tf-DTPA-Gd and Tf-DTPA-Gd were injected into mice via tail vein respectively, and 4 hours later single-photon emission computed tomography(SPECT)/ computed tomography (CT) and magnetic resonance imaging (MRI) were acquired. The values of target-to-muscle ratios (T/M) and relative signal enhancement (rSE) were calculated by drawing regions of interest (ROI) in tumors. H-E staining and immunohistochemistry detection were applied when imaging was completed. Statistical analysis was performed using two-sample t test. Results: The tumors were clearly visible except PC-3 after administration with 99mTc-Tf-DTPA-Gd. The value of T/M between MDA-MB-468 and PC-3 showed statistically significant difference (t=6.919, P=0.002). In MRI experiment, the tumor of MDAMB-468 was enhanced distinctly, while the signal of PC-3 tumor approximated the pre-injection. The rSE between MDA-MB-468 and PC-3 also showed statistically significant difference (t=8.441, P=0.001). Immunohistochemistry staining showed 9 of these xenograft tumor models expressing TfR in various degree rather than PC-3 tumor. Conclusion: 99mTc-Tf-DTPA-Gd could serve as an ideal probe for detecting tumor TfR expression in vivo noninvasively.
Keywords:Transferrin receptor  Molecular imaging  Dual-modality  Magnetic resonance imaging  Immunohistochemistry  
点击此处可从《中国癌症杂志》浏览原始摘要信息
点击此处可从《中国癌症杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号